Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine (Text with EEA relevance)
| Amendments and corrections | |
|---|---|
| June 14, 2021 | Entry into force - Date pub. +20 See Art 5 |
| Consolidated texts |
|---|